Back to BAX Stock Lookup

Baxter Int\'l (BAX) – Press Releases

Dec 17, 2014 04:15 PM Baxter International Fourth Quarter 2014 Financial Results Conference Call
Dec 15, 2014 09:00 AM Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics
Dec 10, 2014 05:15 PM Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin off of Biopharmaceuticals Business
Dec 9, 2014 09:00 AM Baxter’s Culture of Community Engagement and Inclusion Recognized by Leading Organizations
Dec 4, 2014 08:00 AM Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398, Nanoliposomal Irinotecan (nal-IRI), Published in Cancer Research
Dec 1, 2014 09:00 AM Baxter Submits Application for U.S. FDA Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A
Nov 19, 2014 08:00 AM Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer
Nov 13, 2014 04:15 PM Baxter to Present at the 26th Annual Piper Jaffray Healthcare Conference
Nov 11, 2014 09:05 AM Baxter Declares Quarterly Dividend
Nov 6, 2014 08:30 AM Merrimack Pharmaceuticals Announces Initiation of Phase 1 Clinical Study of MM-398 for Brain Cancer
Nov 5, 2014 04:15 PM Baxter to Present at the Stifel 2014 Healthcare Conference
Oct 30, 2014 09:00 AM Baxter’s Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study
Oct 24, 2014 09:00 AM FDA Approves Baxter’s OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], for Acquired Hemophilia A
Oct 22, 2014 04:15 PM Baxter to Present at the 2014 Credit Suisse Healthcare Conference
Oct 20, 2014 09:00 AM Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency
Oct 16, 2014 07:00 AM Baxter’s Third Quarter Financial Results Exceed Guidance
Oct 9, 2014 04:35 PM Baxter International Third Quarter 2014 Financial Results Conference Call
Oct 8, 2014 09:15 AM Baxter Recognized for Commitment to Women's Healthcare Careers
Oct 3, 2014 07:00 AM Rockwell Medical Enters Into Exclusive Long-Term Agreement With Baxter Healthcare to Commercialize Rockwell's Hemodialysis Concentrates
Oct 1, 2014 09:15 AM Baxter International Inc. Recognized by Healthcare Businesswomen’s Association with ACE Award for Its Baxter Women Leaders Business Resource Group
Sep 29, 2014 04:15 PM Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
Sep 26, 2014 04:56 AM PharmaEngine and Merrimack Amend MM-398 License Agreement
Sep 25, 2014 04:15 PM Baxter International Third Quarter 2014 Financial Results Conference Call
Sep 24, 2014 07:00 AM Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398

Back to BAX Stock Lookup